nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Parkinson's disease	0.907	1	CbGaD
Etravirine—Rilpivirine—ABCB1—Parkinson's disease	0.00333	1	CrCbGaD
Etravirine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000512	0.0057	CbGpPWpGaD
Etravirine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00051	0.00568	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—CP—Parkinson's disease	0.00049	0.00546	CbGpPWpGaD
Etravirine—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000473	0.00527	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000473	0.00526	CbGpPWpGaD
Etravirine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000466	0.0052	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.000466	0.00519	CbGpPWpGaD
Etravirine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000444	0.00495	CbGpPWpGaD
Etravirine—CYP2C19—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000442	0.00492	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000434	0.00483	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000433	0.00483	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000431	0.0048	CbGpPWpGaD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000428	0.00476	CbGpPWpGaD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000396	0.00441	CbGpPWpGaD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000395	0.0044	CbGpPWpGaD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000391	0.00436	CbGpPWpGaD
Etravirine—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00039	0.00434	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—DDC—Parkinson's disease	0.000387	0.00431	CbGpPWpGaD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000375	0.00418	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000367	0.00408	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTA4—Parkinson's disease	0.000365	0.00407	CbGpPWpGaD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000361	0.00402	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000361	0.00402	CbGpPWpGaD
Etravirine—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000357	0.00397	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000351	0.00391	CbGpPWpGaD
Etravirine—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000333	0.00371	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PLA2G6—Parkinson's disease	0.000329	0.00366	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—MAOB—Parkinson's disease	0.000326	0.00363	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000321	0.00358	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00032	0.00357	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00031	0.00345	CbGpPWpGaD
Etravirine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000308	0.00343	CbGpPWpGaD
Etravirine—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000303	0.00338	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000295	0.00328	CbGpPWpGaD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000293	0.00326	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000293	0.00326	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000291	0.00325	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000284	0.00317	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.000282	0.00314	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000278	0.00309	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000275	0.00306	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000264	0.00294	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000261	0.0029	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000257	0.00286	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000257	0.00286	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000253	0.00282	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.000251	0.0028	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000246	0.00274	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP2D6—Parkinson's disease	0.000242	0.0027	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000241	0.00268	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000238	0.00265	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CTGF—Parkinson's disease	0.000238	0.00265	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000235	0.00262	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000229	0.00255	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP2E1—Parkinson's disease	0.000221	0.00247	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—NQO1—Parkinson's disease	0.000219	0.00244	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000219	0.00244	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—TH—Parkinson's disease	0.000216	0.0024	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000211	0.00235	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYCS—Parkinson's disease	0.000207	0.00231	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000204	0.00228	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000193	0.00215	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000187	0.00208	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000184	0.00205	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—COMT—Parkinson's disease	0.000183	0.00204	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTP1—Parkinson's disease	0.000183	0.00203	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—MAOA—Parkinson's disease	0.000182	0.00203	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—HMOX1—Parkinson's disease	0.00018	0.00201	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ABCB1—Parkinson's disease	0.000173	0.00192	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000171	0.0019	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00017	0.0019	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00017	0.0019	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.00017	0.00189	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000169	0.00189	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000168	0.00187	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000168	0.00187	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTM1—Parkinson's disease	0.000168	0.00187	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000167	0.00186	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GPX1—Parkinson's disease	0.000161	0.00179	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000159	0.00177	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000156	0.00174	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000156	0.00173	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000153	0.00171	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000151	0.00168	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—MTHFR—Parkinson's disease	0.000148	0.00165	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000142	0.00158	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000141	0.00158	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000141	0.00157	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.00014	0.00156	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000139	0.00155	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000139	0.00155	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—APOE—Parkinson's disease	0.000138	0.00154	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000129	0.00144	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000129	0.00144	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000128	0.00143	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000128	0.00143	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000128	0.00142	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000127	0.00142	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000127	0.00141	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000123	0.00138	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000123	0.00137	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000123	0.00137	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000122	0.00135	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000118	0.00131	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—INS—Parkinson's disease	0.000118	0.00131	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000116	0.0013	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000112	0.00125	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000111	0.00123	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000108	0.0012	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000103	0.00114	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000101	0.00113	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	9.74e-05	0.00108	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MCCC1—Parkinson's disease	9.17e-05	0.00102	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ND3—Parkinson's disease	9.17e-05	0.00102	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	9.04e-05	0.00101	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—Parkinson's disease	8.95e-05	0.000997	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MCCC1—Parkinson's disease	8.95e-05	0.000997	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ND3—Parkinson's disease	8.95e-05	0.000997	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.88e-05	0.000989	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—OMD—Parkinson's disease	8.62e-05	0.00096	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TALDO1—Parkinson's disease	8.62e-05	0.00096	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	8.5e-05	0.000947	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	8.46e-05	0.000943	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	8.44e-05	0.00094	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—OMD—Parkinson's disease	8.41e-05	0.000937	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TALDO1—Parkinson's disease	8.41e-05	0.000937	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	8.39e-05	0.000934	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ND3—Parkinson's disease	8.36e-05	0.000931	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	8.36e-05	0.000931	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	8.35e-05	0.00093	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	8.32e-05	0.000926	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	8.17e-05	0.00091	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	7.98e-05	0.000889	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—OMD—Parkinson's disease	7.86e-05	0.000876	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	7.86e-05	0.000876	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GCH1—Parkinson's disease	7.8e-05	0.000868	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.78e-05	0.000866	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.67e-05	0.000854	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GCH1—Parkinson's disease	7.61e-05	0.000848	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	7.45e-05	0.00083	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GCH1—Parkinson's disease	7.11e-05	0.000792	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	7.03e-05	0.000783	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—FBP1—Parkinson's disease	6.95e-05	0.000774	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GBA—Parkinson's disease	6.95e-05	0.000774	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—DBH—Parkinson's disease	6.95e-05	0.000774	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—DBH—Parkinson's disease	6.78e-05	0.000756	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—FBP1—Parkinson's disease	6.78e-05	0.000756	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GBA—Parkinson's disease	6.78e-05	0.000756	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.41e-05	0.000714	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—FBP1—Parkinson's disease	6.34e-05	0.000706	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GBA—Parkinson's disease	6.34e-05	0.000706	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—DBH—Parkinson's disease	6.34e-05	0.000706	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	6.07e-05	0.000677	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.93e-05	0.00066	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.69e-05	0.000634	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	5.58e-05	0.000622	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ND3—Parkinson's disease	5.51e-05	0.000614	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.51e-05	0.000614	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	5.18e-05	0.000577	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—OMD—Parkinson's disease	5.18e-05	0.000577	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—DDC—Parkinson's disease	5.1e-05	0.000568	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—DDC—Parkinson's disease	4.98e-05	0.000555	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.95e-05	0.000551	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.91e-05	0.000547	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	4.82e-05	0.000537	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.76e-05	0.00053	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTA4—Parkinson's disease	4.7e-05	0.000524	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.69e-05	0.000522	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—DDC—Parkinson's disease	4.65e-05	0.000518	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.42e-05	0.000492	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	4.39e-05	0.000489	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	4.34e-05	0.000483	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.34e-05	0.000483	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MAOB—Parkinson's disease	4.29e-05	0.000478	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.23e-05	0.000472	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MAOB—Parkinson's disease	4.19e-05	0.000467	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—DBH—Parkinson's disease	4.18e-05	0.000465	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FBP1—Parkinson's disease	4.18e-05	0.000465	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GBA—Parkinson's disease	4.18e-05	0.000465	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.09e-05	0.000455	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.95e-05	0.00044	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.91e-05	0.000436	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.73e-05	0.000415	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	3.19e-05	0.000355	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CTGF—Parkinson's disease	3.13e-05	0.000349	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.11e-05	0.000347	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—DDC—Parkinson's disease	3.07e-05	0.000342	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CTGF—Parkinson's disease	3.06e-05	0.000341	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.92e-05	0.000325	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.91e-05	0.000324	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.9e-05	0.000323	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.89e-05	0.000321	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.86e-05	0.000318	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.85e-05	0.000317	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TH—Parkinson's disease	2.84e-05	0.000317	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NQO1—Parkinson's disease	2.82e-05	0.000314	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TH—Parkinson's disease	2.78e-05	0.000309	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.73e-05	0.000304	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYCS—Parkinson's disease	2.67e-05	0.000297	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.66e-05	0.000296	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.63e-05	0.000293	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.61e-05	0.00029	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TH—Parkinson's disease	2.59e-05	0.000289	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.58e-05	0.000288	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.49e-05	0.000277	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—COMT—Parkinson's disease	2.42e-05	0.000269	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.41e-05	0.000268	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.4e-05	0.000267	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2.37e-05	0.000264	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—COMT—Parkinson's disease	2.36e-05	0.000263	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.35e-05	0.000262	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MAOA—Parkinson's disease	2.34e-05	0.000261	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.32e-05	0.000258	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	2.28e-05	0.000254	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	2.21e-05	0.000246	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—COMT—Parkinson's disease	2.2e-05	0.000246	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	2.19e-05	0.000244	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MAOA—Parkinson's disease	2.19e-05	0.000244	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	2.16e-05	0.000241	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.16e-05	0.00024	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.12e-05	0.000236	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	2.08e-05	0.000231	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GPX1—Parkinson's disease	2.07e-05	0.00023	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	2.02e-05	0.000225	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.95e-05	0.000218	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.93e-05	0.000215	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.92e-05	0.000214	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.91e-05	0.000213	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.88e-05	0.00021	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOE—Parkinson's disease	1.82e-05	0.000203	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.78e-05	0.000199	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOE—Parkinson's disease	1.78e-05	0.000198	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.75e-05	0.000195	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.74e-05	0.000193	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TH—Parkinson's disease	1.71e-05	0.00019	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOE—Parkinson's disease	1.66e-05	0.000185	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.64e-05	0.000183	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—INS—Parkinson's disease	1.55e-05	0.000173	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—INS—Parkinson's disease	1.52e-05	0.000169	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.45e-05	0.000162	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.45e-05	0.000161	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.44e-05	0.000161	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.43e-05	0.000159	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—INS—Parkinson's disease	1.42e-05	0.000158	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.37e-05	0.000153	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.33e-05	0.000148	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.27e-05	0.000142	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.18e-05	0.000131	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOE—Parkinson's disease	1.09e-05	0.000122	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—INS—Parkinson's disease	9.35e-06	0.000104	CbGpPWpGaD
